ABSTRACT
There is apparently no doubt for anyone that modern life science research based on the new high-throughput technologies most prominently represented by genomic sequencing together with the increasingly powerful and, at the same time, affordable information technology products will
dramatically change healthcare. The main idea behind these expectations is that the new availability of data characterizing the patients’ individuality at the level of genome, biomolecules and gene/protein networks together with evermore powerful diagnostic, mainly imaging tools at the histological, anatomical and physiological levels allow ever finer stratification of the patients’ conditions once the molecular data is integrated with clinical data and, finally, it will lead to the design of personalized treatment regimes.
